Edition:
United States

Kyorin Holdings Inc (4569.T)

4569.T on Tokyo Stock Exchange

2,371JPY
24 Feb 2017
Change (% chg)

¥-3 (-0.13%)
Prev Close
¥2,374
Open
¥2,360
Day's High
¥2,376
Day's Low
¥2,343
Volume
266,500
Avg. Vol
179,772
52-wk High
¥2,700
52-wk Low
¥1,842

4569.T

Chart for 4569.T

About

KYORIN Holdings, Inc. is a Japan-based holding company mainly engaged in the manufacture and sale of pharmaceuticals. The Company operates in two business segments. The Pharmaceuticals segment is engaged in the manufacture, purchase and sale of pharmaceutical products, the evaluation of technologies, the inspection, analysis and... (more)

Overall

Beta: 0.65
Market Cap(Mil.): ¥177,925.70
Shares Outstanding(Mil.): 74.95
Dividend: 38.00
Yield (%): 2.44

Financials

  4569.T Industry Sector
P/E (TTM): 23.21 28.90 29.71
EPS (TTM): 102.27 -- --
ROI: 4.51 13.43 12.94
ROE: 4.79 14.33 14.09

BRIEF-R&I affirms KYORIN Holdings Inc's rating at "A-" and announces stable outlook -R&I

* Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A-" -R&I

Feb 09 2017

BRIEF-Kyorin Holdings unit forms sales business alliance with Air Liquide Japan, Ltd.

* Says its unit formed sales business alliance with Air Liquide Japan, Ltd.

Jan 10 2017

BRIEF-KYORIN Holdings unit grants MSD K.K. manufacturing and marketing rights for medicine of allergic diseases

* Says MSD K.K. received a manufacturing and marketing approval for DESALEX Tablets 5mg for the treatment of allergic diseases from the co's unit KYORIN Pharmaceutical Co., Ltd.

Sep 28 2016

BRIEF-KYORIN Holdings unit enters into co-promotion agreement with MSD K.K

* Says its unit Kyorin Pharmaceutical Company Limited enters into agreement with MSD K.K, on co-promotion of an allergic rhinitis treatment, since Nov. 1

Sep 15 2016

More From Around the Web

Earnings vs. Estimates